Second-line FOLFOX is not the standard of care for all patients with advanced biliary tract cancer—a commentary from the Young International Society of Geriatric Oncology

G. Liposits, S. P. Arora, N. M.L. Battisti, E. Soto-Perez-de-Celis, K. P. Loh, G. R. Williams

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)555-556
Number of pages2
JournalAnnals of Oncology
Issue number6
StatePublished - Jun 2023

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this